|
(V971) |
Atrial Fibrillation Patterns, Predictors of AF Progression and Outcome – the PREFER in AF Registries |
| |
|
R. Schnabel, L. Pecen, D. Engler, M. Lucerna, J. M. Sellal, F. Ojeda-Echevarria, R. De Caterina, P. Kirchhof, für die Studiengruppe: PREFER in AF (Hamburg, München; Prague, CZ; Nancy, FR; Chieti, IT; Birmingham, UK) |
|
|
Diskussion |
|
(V972) |
INCIDENCE and characteristics of asymptomatic atrial fibrillation after ablation: iNSIGHTS FROM REMOTE CARDIAC MONITORING |
| |
|
A. C. Schwab, S. Butz, D. Edler, A. Vevecka, M. Forkmann, I. Ajmi, O. Turschner, J. Brachmann, S. Busch (Coburg) |
|
|
Diskussion |
|
(V973) |
Current practice of antithrombotic treatment in patients with atrial fibrillation: Data from the German Atrial Fibrillation NETwork (AFNET) Registry 2. |
| |
|
A. Gerth, M. Näbauer, P. Kirchhof, G. Steinbeck, G. Breithardt, für die Studiengruppe: AFNET eV (München, Starnberg, Münster; Birmingham, UK) |
|
|
Diskussion |
|
(V974) |
Effectiveness and safety of reduced and standard dose non-vitamin K antagonist oral anticoagulants and phenprocoumon in patients with atrial fibrillation: Insights from a large German claims database |
| |
|
M. Näbauer, E. Basic, C. Hohmann, S. Hohnloser (München, Berlin, Köln, Frankfurt am Main) |
|
|
Diskussion |
|
(V975) |
Clinical characteristics and outcome of patients undergoing AV-node ablation versus pulmonary vein isolation for symptomatic atrial fibrillation – results from the German Ablation Registry |
| |
|
K. Wasmer, M. Hochadel, H. Wieneke, S. G. Spitzer, J. Brachmann, E. Hoffmann, J. Tebbenjohanns, G. Groschup, A. Heisel, T. Lewalter, J. Senges, L. Eckardt (Münster, Ludwigshafen am Rhein, Essen, Dresden, Coburg, München, Hildesheim, Aschaffenburg, Wilhelmshaven) |
|
|
Diskussion |
|
(V976) |
Comparative risk of stroke and bleeding with non-vitamin K oral anticoagulants in comparison to phenprocoumon: Data from 61,000 patients with atrial fibrillation |
| |
|
S. Hohnloser, E. Basic, C. Hohmann, M. Näbauer (Frankfurt am Main, Berlin, Köln, München) |
|
|
Diskussion |